Skip to main content
Top

Drugs

Issue 16/2007

Content (11 Articles)

Adjuvant Therapy in Pancreatic Cancer

  • Current Opinion

Helmut Oettle, Peter Neuhaus

Hormone Therapy for the Prevention of Bone Loss in Menopausal Women with Osteopenia

  • Current Opinion

Mary H. Hohenhaus, Kelly A. McGarry, Nananda F. Col

Pathophysiology and Management of Opioid-Induced Pruritus

  • Therapy In Practice

Arjunan Ganesh, Lynne G. Maxwell

Estrogen Receptor Modulators and Down Regulators

  • Review Article

Christa K. Baumann, Monica Castiglione-Gertsch

Multidrug-Resistant Streptococcus pneumoniae Infections

  • Review Article

Françoise Van Bambeke, René R. Reinert, Peter C. Appelbaum, Paul M. Tulkens, Willy E. Peetermans

Salmeterol/Fluticasone Propionate

  • Adis Drug Evaluation

Gillian M. Keating, Paul L. McCormack

Budesonide/Formoterol

  • Adis Drug Evaluation

Paul L. McCormack, Katherine A. Lyseng-Williamson

Celecoxib

  • Adis Drug Evaluation

James E. Frampton, Gillian M. Keating

Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg

  • Adis Drug Profile

Antona J. Wagstaff

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images